ResearchMoz

China Medical Monitor Industry Report, 2013 - 2015

Research In China
Published Date » 2013-12-23
No. Of Pages » 61
In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of which, multi-parameter monitor market size accounted for more than 60%. 

China is a major exporter of monitor, in 2006-2012 the export volume grew at a CAGR of 22.9%. From January to October of 2013 China’s export volume of medical monitors climbed 16.7% YoY. Meanwhile, many of high-end medical monitors in China are still dependent on imports, 80% of the medium- and high-end monitor market was occupied by General Electric (GE), Philips and other foreign brands. 

Medical monitor pertains to the high-tech, high value-added product, with high levels of industry profit. In 2008-2013 China’s major monitor enterprises e.g. Mindray, Biolight and EDAN Instruments kept gross margin around 50%. 

With the improvement of living standards and aging of population in China, medical monitor will be extended from medical institution to home health care, and household multi-parameter monitor will become a new growth engine of consumption, which will consolidate the market position of multi-parameter monitor. Meanwhile, accompanied by the family planning policy adjustments, obstetric monitor embraces a positive outlook. 

The Chinese medical monitor market size is expected to achieve RMB7.42 billion in 2015, of which, multi-parameter monitor market size and obstetric care market size will be RMB4.412 billion and RMB588 million, respectively. 
Table of Content

1. Overview of Medical Monitor Industry
1.1 Definition
1.2 Classification

2. Status Quo of China Medical Monitor Industry
2.1 Medical Devices Market 
2.2 Monitor Market
2.3 Monitor Import & Export
2.3.1 Import
2.3.2 Export
2.4 Monitor Competition 
2.5 Profit Level
2.6 Entry Barriers  
2.6.1 Market Access Barriers
2.6.2 Technical Barriers
2.6.3 Capital Barriers
2.6.4 Talent Barriers
2.7 Technical Levels and Trends
2.7.1 Modular Technology
2.7.2 Machine Technology 
2.7.3 Informatization Technology

3. Environment for China Medical Monitor Development
3.1 Policy Environment
3.1.1 Industry Planning
3.1.2 Regulatory Policies
3.1.3 Import and Export Policies
3.2 Upstream and Downstream Industries
3.2.1 Upstream Sectors
3.2.2 Downstream Sectors

4. Key Companies
4.1 GE
4.1.1 Profile
4.1.2 Operation
4.1.3 Medical Monitor Business
4.2 Philips
4.2.1 Profile
4.2.2 Operation
4.2.3 Medical Monitor Business
4.3 Nihon Kohden
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D
4.3.6 Business in China
4.4 Fukuda
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Monitor Business
4.4.5 Business in China
4.5 Mindray
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Medical Monitor Business
4.6 Biolight
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D and Investment
4.6.6 Main Clients
4.7 EDAN Instruments, INC.
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 R&D and Investment
4.7.6 Main Clients
4.8 Shenzhen Creative Industry Co., Ltd.
4.8.1 Profile
4.8.2 Operation
4.9 Beijing Choice Electronic Tech Co., Ltd (ChoiceMMed)
4.9.1 Profile
4.9.2 Operation
4.9.3 Development
4.10 Tianrong Medical & Communication Equipment Co., Ltd
4.10.1 Profile
4.10.2 Operation
4.10.3 Development

5. Summary and Forecast
5.1 Summary for Monitor Enterprises
5.1.1 Monitor Product Revenue
5.1.2 R&D
5.1.3 Gross Margin
5.2 Demand Forecasting
5.3 Overall Demand Forecasting
5.4 Breakdown Product Demand Analysis
5.4.1 Multi-parameter Monitor
5.4.2 Obstetric Monitor

List of Tables


List of Figures

Upcoming Reports:

Home Medical Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
The global home medical equipment consumption pattern will depend on demographic and epidemiological development. Increased efforts in the fight against chronic illnesses such as respiratory diseases, kidney disorders, and cancer will boost the demand for home therapeutic devices. Products such as portable oxygen concentrators, continuous positive airway products, ventilators, and other accessories will undergo the fastest growth in sales in this market. Increasing numbers of baby boomers and an increase in the population of aged people on a global scale will also assist in the growth...
Carotenoids Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Carotenoids are the organic pigments naturally occurring in plants and have been used for food colorings with beta- carotene for a long time. However, with continuous research and development, carotenoids have found relevance in feeds and food supplements. The market is expected to exhibit a marginal growth compared to previous years. The majority of sales of the global carotenoids market come from the mature markets such as North America and Europe. Markets such as Asia Pacific and the rest of the world are expected to exhibit sizeable growth in the coming years and Europe...
Therapeutics For Memory And Cognition Disorders - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 - 2019
By - Transparency Market Research
Memory and cognitive disorders are mental health disorders that primarily affect learning, memory, perception and problem solving ability. The global market of therapeutics for memory and cognition disorders is witnessing a significant growth over recent years due to aging population in different parts of the world, new drugs development and better understanding of drugs mechanism. However, less number of approved drugs is a major restraint for the market growth. Also, ethical implication has become a major challenge for the market.     Global market of therapeutics for...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...